Chemical inhibitors of OTTMUSG00000005523 include a range of compounds that target various signaling pathways and cellular processes to achieve functional inhibition. Blebbistatin, for instance, directly inhibits the myosin II ATPase activity. By doing so, it undermines the contractile mechanisms that are essential for the physiological role of OTTMUSG00000005523. This action results in a decrease in cellular motility and contractility, processes which OTTMUSG00000005523 could be crucially involved in. Similarly, Y-27632 acts by inhibiting ROCK kinase, a downstream effector in the Rho signaling pathway. Since ROCK kinase is involved in the phosphorylation of substrates that could be fundamental to the function of OTTMUSG00000005523, its inhibition by Y-27632 can lead to a reduction in the protein's activity. ML-7 takes a parallel approach by inhibiting myosin light chain kinase, which is also implicated in phosphorylation events that are likely critical for OTTMUSG00000005523 function. By inhibiting this kinase, ML-7 disrupts the phosphorylation state of myosin light chains, hence affecting the protein's activity.
Further down the list, Gö6976 works by inhibiting protein kinase C (PKC), which is known to phosphorylate a wide range of target proteins that could include OTTMUSG00000005523 or its partners. Inhibition of PKC by Gö6976 therefore could lead to a reduction in OTTMUSG00000005523 activity due to decreased phosphorylation. PD98059, by inhibiting MEK, leads to diminished MAPK/ERK pathway activity, which is often implicated in cell proliferation and differentiation signals that OTTMUSG00000005523 may be a part of. LY294002 and Wortmannin, both PI3K inhibitors, disrupt PI3K-dependent signaling pathways, which could directly impact the signaling cascades involving OTTMUSG00000005523. U73122 inhibits phospholipase C, thereby potentially disrupting the production of second messengers and the subsequent signaling that may regulate OTTMUSG00000005523. SB203580 and SP600125 target p38 MAP kinase and JNK, respectively, which are stress-activated protein kinases that could regulate the activity of OTTMUSG00000005523 through their effects on cellular stress responses. Lastly, PP2 and KN-93 inhibit Src family kinases and CaMKII, respectively, with Src kinases being involved in numerous signaling pathways and CaMKII playing a role in calcium signaling, both of which are fundamental to the function of OTTMUSG00000005523 in cellular signaling contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibits myosin II ATPase activity, possibly reducing the contractility OTTMUSG00000005523 relies on for function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK kinase which could reduce phosphorylation events required for OTTMUSG00000005523 activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, potentially decreasing phosphorylation necessary for OTTMUSG00000005523. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Inhibits protein kinase C, which might be involved in regulating OTTMUSG00000005523 through phosphorylation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may lead to reduced MAPK/ERK pathway activity, affecting OTTMUSG00000005523 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially disrupting signaling pathways that OTTMUSG00000005523 is involved in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase potentially decreasing the phosphorylation state of substrates involved with OTTMUSG00000005523. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, possibly affecting signaling pathways that regulate OTTMUSG00000005523 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which might affect the signaling processes and pathways OTTMUSG00000005523 is part of. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, potentially altering signaling cascades essential for OTTMUSG00000005523 activity. | ||||||